Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.
The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.
“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.
During the AANS, joimax® participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.
Press Contact Germany:
Phone 0049 721 25514 0
Press Contact USA:
Phone 001 949 859 3472